chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a registered nurse concerning a 22 year old female who on 08-JUN-2009 was vaccinated with her first dose of GARDASIL. On the same date the patient experienced nausea, dizziness and lightheadedness. The patient's reaction to GARDASIL was the same to TYLENOL and aspirin. On an unknown date the patient recovered. The patient sought medical attention via speaking to nurse in office. Follow-up information was received from the registered nurse concerning a 22 year old female patient with depression, allergic rhinitis and TYLENOL allergy who on 08-JUN-2009 was intramuscularly vaccinated with her first dose of GARDASIL (lot number 662229/1497X) in her right deltoid. The patient was well at time of vaccination. It was reported that 5 to 10 minutes after administration, the patient became nauseated, dizzy, lightheaded and shaky. She reported this experience when she came in office for her second dose of GARDASIL. Because she stated that this response was similar with TYLENOL (which she was allergic to), after discussion, it was decided she should not take the second dose of GARDASIL. On 08-JUN-2009 the patient recovered. Additional information is not expected.
bad case of dizzy; Nausea; head rolling; cannot do anything; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 26Feb2021 (Batch/Lot number: unknown) as dose number, unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious) with onset 27Feb2021, outcome "unknown", described as "bad case of dizzy"; NAUSEA (non-serious) with onset 27Feb2021, outcome "unknown", described as "Nausea"; VERTIGO (non-serious) with onset 27Feb2021, outcome "unknown", described as "head rolling"; HYPOKINESIA (non-serious) with onset 27Feb2021, outcome "unknown", described as "cannot do anything".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
States that arm still aches and is painful such that she cannot sleep on that side. The pain has not changed since she got the shot. (No increase or decrease). I suggested that she see her physician.
death I63.9 - Cerebral infarction, unspecified J96.01 - Acute respiratory failure with hypoxia J12.82 - Pneumonia due to coronavirus disease 2019 N17.9 - Acute kidney failure, unspecified
pt recvd vax & devel fever of 102-106; pt devel myalgias, fatigue, malaise, shaking, chills, weakness, & joint aches & pains; pt later devel yellowing of the sclera of eyes & skin; pt taken to MD;
Shoulder pain / left shoulder as the area of concern; Had sever problems with her left arm; This case was reported by a consumer via call center representative and described the occurrence of shoulder pain in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced shoulder pain and arm discomfort. On an unknown date, the outcome of the shoulder pain and arm discomfort were not recovered/not resolved.   It was unknown if the reporter considered the shoulder pain and arm discomfort to be related to Shingrix.  Additional details were provided as follows: Age at vaccination was not reported. The reporter was the patients husband. The reporter reported that his wife had severe problems with her left arm after receiving the Shingrix vaccine about three months ago. The patient went to a chiropractor, then to a shoulder specialist, and was now in physical therapy. The reporter did not consent to follow-up.
Systemic: shingles-Medium, Additional Details: shingles behind the eye that has spread to the eye according to mom. is being treated by an eye doctor.
Pt received his vaccine and returned to the waiting room. Within 5 minutes he slumped to the floor, he lost consciousness and had a brief seizure lasting less than 30 seconds There was a sheriff deputy in the waiting area that asked him his name, year, president and where he was. He was able to answer all questions, but was still shaking. We called 911 and EMTs were here within 2 minutes and took over.  After assessing him and taking his vitals they decided to transport him to Hospital.
Encounter for vaccination: -     AGE 6 WKS-4 YRS DTAP-IPV-HIB-HEP B (DIPH/TET/PERTUS, POLIOVIRUS, HAEMOPH INFL TYPE B, HEP B) VACCINE <VAXELIS> -     AGE 0-18 YRS PCV-13 (PNEUMOCOCCAL, 13-VALENT) VACCINE <PREVNAR-13> -     AGE 6 - 24 WKS ROTAVIRUS (MONOVALENT) VACCINE <ROTARIX> 12/08/2022 1620 Patient Care Technician was informed in the waiting area by the parent of the child he had developed a rash after the vaccines.  Pt. was already discharged. Technician brought patient to an exam room. Charge Nurse was of the development of rash and orders. Pt. developed a rash on forehead, cheeks, and left forearm after administration of vaccines.  Due to the allergic reaction to vaccines, pt received diphenhydramine (BENADRYL) 6.25 mg by mouth x1. Pt. alert, BBS present and clear. Pulse ox 99%, HR 138, RR 28.  12/08/2022 1636 Pt. with no distress.  Rash had resolved. BBS present and clear.
nausea (3-4 hours) followed by vomiting (8-10 hours) and complete recovery
Information has been received from a nurse and a medical assistant concerning a female patient who in December 2008, was vaccinated with a dose of PNEUMOVAX (Lot n. 659922/1667U) 0.5 ml.  In December 2008, the patient experienced pain, swelling and warmth at the injection site.  Follow up information received from the medical assistant reported that the patient was a 75 year old female.  The patient's pain, swelling and warmth at the injection site had resolved.  Additional information has been requested.
minor hives, then swelling of airway, trouble swallowing and breathing, 911 was called - ER administered IV Benadryl STAT and then Prednisone orally and Zantac.  IV drip and observation for several hours.  Monitor of heart and several exams of airway and outside of throat. hives were about 3 hrs. after shot airway was about 6 hours after shot
Swelling and spreading rash at injection site. Axillary pain on side of injection site. Both started on Day 6 after vaccine and resolved on Day 10 after vaccine
Case number PHEH2014US002500 is an initial spontaneous report received from a pharmacist on 03 Feb 2014: This report refers to a female patient of unknown age. She was administered FLUVIRIN (batch number: 13413P) intramuscularly on 28 Jan 2014. During administering the vaccine, part of it leaked out of the needle before entering her arm. Therefore, the patient did not receive a full 0.5 ml dose. No adverse event was reported following this administration error.
redness over the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (redness over the injection site) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (redness over the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (redness over the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment medications were reported.
Information has been received from a medical assistant concerning a 16 year old patient who "last week" was accidentally vaccinated with ZOSTAVAX (Merck). Additional information has been requested.
I experienced fever, fatigue, body aches, and just felt sick for approximately 9 days. I went to Urgent Care on 09/07/2021 because the sinus infection set my Trigeminal Neuralgia. The doctor diagnosed me with Kidney and Sinus infection and prescribed Clindamycin. The medication works but has not resolved the symptoms yet. I have had the sinus infection for over a month which is very unusual for me. PCP performed a COVID test as a precaution which came back negative. Kidney infection has since cleared up but the sinus infection continues per my PCP 10/05/2021 (gives me a bad taste and smell).
it turned into pain at the base of his neck down into his spine; hasn't been able to work because of this; has not gotten 2nd dose; had a cramp in his neck; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (had a cramp in his neck), NECK PAIN (it turned into pain at the base of his neck down into his spine), IMPAIRED WORK ABILITY (hasn't been able to work because of this) and PRODUCT DOSE OMISSION ISSUE (has not gotten 2nd dose) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Oct-2021, the patient experienced MUSCLE SPASMS (had a cramp in his neck). On an unknown date, the patient experienced NECK PAIN (it turned into pain at the base of his neck down into his spine), IMPAIRED WORK ABILITY (hasn't been able to work because of this) and PRODUCT DOSE OMISSION ISSUE (has not gotten 2nd dose). The patient was treated with Physical therapy (physical therapy) for Neck pain. At the time of the report, MUSCLE SPASMS (had a cramp in his neck), NECK PAIN (it turned into pain at the base of his neck down into his spine) and IMPAIRED WORK ABILITY (hasn't been able to work because of this) had not resolved and PRODUCT DOSE OMISSION ISSUE (has not gotten 2nd dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were provided.  Patient had not received the 2nd dose. The day after getting the dose he thought he slept wrong and he had a cramp in his neck, and thought it would go away but it continued, so he saw his doctor who said it should go away, but it didn't, and it turned into pain at the base of his neck down into his spine. Patient was now doing physical therapy & would be getting an MRI.   No treatment medication were given.
Pt said she felt pain moving down her arm, then she felt it in her head. Her eyes rolled back and she began groaning and collapsed. She experienced psychedelic visions while out. Also received HepA and Meningoccocal.
She is seeing people get streptococcal pneumonia right after the shots. They are saying its COVID but they do extensive testing and see its either a bacteria pneumonia or streptococcal pneumonia; This is a spontaneous report received from a contactable reporter (Other HCP).  A female patient received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PNEUMONIA STREPTOCOCCAL (medically significant), outcome "unknown", described as "She is seeing people get streptococcal pneumonia right after the shots. They are saying its COVID but they do extensive testing and see its either a bacteria pneumonia or streptococcal pneumonia". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: negative, notes: nobody comes back positive for COVID. The nurse stated that this has been going on in the hospital and now it's family members and coworkers. She stated her mother and boyfriend are reports.   The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Event PNEUMONIA STREPTOCOCCAL  represents an intercurrent medical condition and unrelated to bnt162b2 .  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-202200276393 Same reporter, drug and event and different patient;US-PFIZER INC-202200276328 Same reporter, drug and event and different patient
Chills, headache, nausea, body ache, light sensitive, eye ache
Patient received the vaccine on 8/6 afternoon. By 8/7 am, she had L ankle pain, stiffness, and a round red mark. DVT and fracture were ruled out. The symptoms lasted for a week and a half before resolving.
Severe debilitating lower back pain and 2 weeks later a dime sized blistering pusey rash over and in the left eyebrow along with sciatic nerve pain in left leg (glutes) up to the knee. Result of shingles vaccination????
Sore arm and fatigue that first evening. I had those for about 24 hours. Miscarriage - I had my first doctor's appt on 4/14/2021 and I found out that there was no embryo - Anembryonic pregnancy (blighted ovum)- my body thought it was pregnant but there was no embryo. I had to take medication to induce the miscarriage - I took that last week on the 20th. I've passed all the tissue but I have to wait for it stop cramping now.
As reported by wife of patient: rash, fever, passing out on Oct 16, 2019
Felt a "stinging" feeling down my arm to my hand/wrist -- slightly up my shoulder to my neck and cheek area . . . this continued on and off for about a week.  After 2nd dose on 3/9/21, taken on the right arm (027A21A), I felt nothing, however the next day the "stinging" feeling came back on the left side and continues on and off currently, but somewhat duller..
Brain fog; Migraine; Night sweats; Headache; Chills; Fever; Tired; This is a spontaneous report from a non-contactable healthcare professional, the patient. A 41-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8735) via an unspecified route of administration in the arm left on 08Apr2021 at 11:45 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation. On 09Apr2021 at 02:00, the patient experienced brain fog, migraine, night sweats, headache, chills, fever and tired. Therapeutic measures were taken as a result of events and included treatment with TYLENOL. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events brain fog, migraine, night sweats, headache, chills, fever and tired were recovered on an unspecified date in Apr2021.   No follow-up attempts are possible. No further information is expected.
The patient reported wheezing, muscle pain, pain in rib cage, difficulty breathing on the day of vaccination. Patient has previous history of asthma and is allergic to dust, grass, and pollen, but not to food or medicine. She also developed burning sensation in urine (as she reported as UTI), but the onset of UTI is unknown. She has never had a UTI before. She did not seek medical care and she took antibiotics for her asthma and UTI. As of 12/14/09, she has recovered, except she is still having mild muscle pain during breathing.  Follow-up information received  RE: Missing information letter dated 1/29/2010. Unfortunately, this information is not available to us. When a report of symptoms suggesting a possible adverse event of interest is received, our team attempts to contact the reporting individual - provided that permission to contact has been granted. We have contacted this patient and he or she has agreed to share his or her contact information with VAERS. E-mail address and phone number provided. Patient's last name corrected
She received her seasonal influenza vaccine on 18 November and approximately 10 days later noted onset of localized redness and swelling associated with mild itching at the site. Over the past week she notes the redness has progressed and now notes a "pimple" at the injection site. She denies pain, swollen nodes, fever/chills, and systemic symptoms. She denies drainage from the injection site. She has received the seasonal influenza vaccine in past years and denies adverse reaction to this vaccine or other vaccines. She denies frequent infections to include skin infections.
Pt recvd 1st dose of Hep B vax 27JUN89 as a result of needle stick; On 01JUL89 devel stiff neck, numbness in lt foot, h/a, tightness around lips, tingling in fingers, & shooting pain in all extremities;
Nausea, headache, chills, fever, muscle aches, fatigue (all night of 3/31 into 4/1)  As of 4/13/21 still have headache, fatigue, and uterine bleeding.
16 year old female, fainted 30 to 60 seconds after receiving a first dose Pfizer vaccine. Patient fell from standing and hit the rear of her head/upper body. Family advised she had not eaten today. Patient was only responsive to painful stimuli. Positioned patient while maintaining spinal immobilization. Unable to obtain blood pressure with manual sphygmomanometer. Bilateral radial pulses present and rapid. Ensured patient was breathing adequately although at a faster rate. EMS called at 15:57, arrived at 16:15, and departed for the hospital at 16:28.
about 12 hours after injection, patients upper arm became very sore/painful. Swelled, turned red, and was hot to the touch. She used ice packs over next 2 days until symptoms subsided. She did not require additional treatment and only reported it upon a return trip to pharmacy on 9/25/19. Area was still slightly red but for most part all symptoms resolved
Initial healthcare professional report received 21 Jan 2010: This patient was vaccinated at schedule with Rabipur (rabies vaccine; batch no. 1726) on 21 Dec 2009, 24 Dec 2009, 28 Dec 2009, 04 Jan 2010 and 17 Jan 2010. After the fourth dose, the patient experienced impotence of legs. On 14 Jan 2010, the patient experienced numbness of legs which developed towards to feet, and became more and more serious. On 18 Jan 2010, the patient experienced standing difficulty (reported as hard to stand) and then hospitalized. On unspecified dates, the patient presented with hypodynamia of legs along with walking difficulty and difficulty of emicion. The doctor excluded Gullain-Barre syndrome, but did not give any other diagnosis. The outcome of the events was not reported.
Parent (mother) called stating child hand a rash around lips and on check shortly after recieving vaccines, this rash vanished from face, but then presented on upper back/neckline and left leg thigh, and on abdomen, pictures of the rash were uploaded into chart, appearing as a slight rash no treatment required.
Patient has had quite a reaction to the shots he received on Wednesday.  On Thanksgiving he ran a fever as high as 103 (and that was after he was given Tylenol), and it didn't start to come down until he was also given ibuprofen and a luke warm bath... and it only came down to 101 at that time.  His fever lasted a few days, and although the fever seems to be gone now, patient is miserable.   For the first few days he had diarrhea, and on Thanksgiving he wouldn't even finish his food. He is coughing and very tired and he seems to be just generally feeling bad.  He is very cranky and he just lays on the carpet crying or screaming. In addition to the above, his whole upper right arm was VERY RED and HOT for 5 or so days.
Information has been received from a licensed practical nurse referring to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 21-MAR-2016 the patient was vaccinated with improperly stored (Oka/Merck) VARIVAX (1350U, lot # L031068 with the expiration date 18-AUG-2017, dose and route were unknown). The patient's concomitant medication was not reported. No adverse effects reported. This is one of two reports received from the same reporter. Additional information is not expected as the reporter did not wish further contact.
This spontaneous report was received from a physician via company representatives and from a support services director concerning to a patient of unknown age and gender. Information about the patient's pertinent medical history, concurrent conditions, drug reactions/allergies and concomitant medications was not reported. On 06-JAN-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23, "10PK-0.5ml SD-PFS LLok wTip" which had the lot # K009874 with expiration date 19-MAR-2016 (dosage number and route of administration were not reported). On an unspecified date, the vaccine had a temperature excursion for 112 hours in which the highest recorded temperature was 59 degrees Fahrenheit (15 degrees Celsius). The vaccine status was reported as "in excursion". The vaccine storage criteria and type were reported as "refrigerator (R)". No adverse effects were reported and no product quality complaint was involved. This is one of the several reports received from the same reporter. Additional information has been requested.
erythema, ecchymosis, pain & edema @ inject site are reported in a pt who recvd 1 dose of flu vax; above sx occurred 12hrs p/flu vax given & resolved w/in 48 hrs;
Extreme dizziness, nausea, fever, aches, lymph nodes in neck on side of vaccination. Vaccine given in r arm, brst cancer was in left side.
Constant headache for weeks; my blood pressure has been off; my eyes are blurry; This is a spontaneous report from a contactable consumer (patient). A non-pregnant female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Left on 01Apr2021 15:30 as dose 2, single for covid-19 immunisation.  Medical history was reported as no. Known allergies were reported as Sulpha. The patient concomitant medications were not reported. Patient did not receive any other vaccine in four weeks.  The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in Arm Left on an unspecified date as dose 1, single for covid-19 immunisation. The patient reported that on 02Apr2021, she experienced constant headache for weeks and after a couple days her blood pressure has been off. Sometimes very high and sometimes normal then her eyes were blurry. Never had any issues with her blood pressure in years. The patient underwent lab tests and procedures which included blood pressure measurement: unknown result on an unspecified date (Sometimes very high and sometimes normal). Adverse events resulted in Doctor or other healthcare professional office/clinic visit. Patient did not have COVID prior vaccination and COVID was not tested post vaccination. The patient received treatment for adverse event as other doses of her existing blood pressure pills. The outcome of events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Approximately 5 minutes post vaccination patient developed hives and wheezing. The patient was given 50mg of Diphenhydramine which resolved her symptoms